NYSE:USNA - USANA Health Sciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$91.41 +0.10 (+0.11 %)
(As of 03/19/2019 04:00 PM ET)
Previous Close$91.31
Today's Range$90.08 - $92.6250
52-Week Range$81.75 - $137.95
Volume157,641 shs
Average Volume176,287 shs
Market Capitalization$2.13 billion
P/E Ratio17.72
Dividend YieldN/A
Beta0.35
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Sensé—beautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Receive USNA News and Ratings via Email

Sign-up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryPersonal Products
SectorMedical
CUSIP90328M10
Phone801-954-7100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.19 billion
Cash Flow$5.9667 per share
Book Value$16.31 per share

Profitability

Net Income$126.22 million

Miscellaneous

Employees1,911
Market Cap$2.13 billion
Next Earnings Date4/23/2019 (Estimated)
OptionableOptionable

USANA Health Sciences (NYSE:USNA) Frequently Asked Questions

What is USANA Health Sciences' stock symbol?

USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."

How will USANA Health Sciences' stock buyback program work?

USANA Health Sciences announced that its Board of Directors has initiated a share repurchase program on Tuesday, October 23rd 2018, which authorizes the company to buyback $150,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to reacquire up to 5.9% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's leadership believes its shares are undervalued.

How were USANA Health Sciences' earnings last quarter?

USANA Health Sciences, Inc. (NYSE:USNA) released its quarterly earnings data on Tuesday, February, 5th. The company reported $1.32 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $1.33 by $0.01. The firm had revenue of $299.02 million for the quarter, compared to analyst estimates of $305.79 million. USANA Health Sciences had a net margin of 10.61% and a return on equity of 30.49%. USANA Health Sciences's revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.11 EPS. View USANA Health Sciences' Earnings History.

When is USANA Health Sciences' next earnings date?

USANA Health Sciences is scheduled to release their next quarterly earnings announcement on Tuesday, April 23rd 2019. View Earnings Estimates for USANA Health Sciences.

What guidance has USANA Health Sciences issued on next quarter's earnings?

USANA Health Sciences updated its FY19 earnings guidance on Tuesday, February, 5th. The company provided earnings per share (EPS) guidance of $5.25-5.55 for the period, compared to the Thomson Reuters consensus estimate of $5.86. The company issued revenue guidance of $1.25-1.30 billion, compared to the consensus revenue estimate of $1.31 billion.

What price target have analysts set for USNA?

2 brokers have issued 1-year target prices for USANA Health Sciences' shares. Their forecasts range from $135.00 to $135.00. On average, they expect USANA Health Sciences' stock price to reach $135.00 in the next year. This suggests a possible upside of 47.7% from the stock's current price. View Analyst Price Targets for USANA Health Sciences.

What is the consensus analysts' recommendation for USANA Health Sciences?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for USANA Health Sciences.

Has USANA Health Sciences been receiving favorable news coverage?

Media stories about USNA stock have been trending neutral recently, InfoTrie reports. The research firm scores the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. USANA Health Sciences earned a media sentiment score of 0.4 on InfoTrie's scale. They also gave news stories about the company a news buzz of 6.0 out of 10, indicating that recent media coverage is somewhat likely to have an effect on the company's share price in the next several days.

Who are some of USANA Health Sciences' key competitors?

What other stocks do shareholders of USANA Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include NVIDIA (NVDA), United Therapeutics (UTHR), Union Pacific (UNP), BioMarin Pharmaceutical (BMRN), Gilead Sciences (GILD), Tesla (TSLA), Johnson & Johnson (JNJ), Zoetis (ZTS), Uniqure (QURE) and Tableau Software (DATA).

Who are USANA Health Sciences' key executives?

USANA Health Sciences' management team includes the folowing people:
  • Dr. Myron W. Wentz, Founder & Chairman (Age 78)
  • Mr. Kevin G. Guest, CEO & Director (Age 56)
  • Mr. Jim Brown, Pres & COO (Age 50)
  • Mr. G. Douglas Hekking, Chief Financial Officer (Age 49)
  • Mr. Daniel A. Macuga Jr., Chief Communications & Marketing Officer (Age 49)

Who are USANA Health Sciences' major shareholders?

USANA Health Sciences' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (4.54%), Acadian Asset Management LLC (3.58%), Dimensional Fund Advisors LP (2.62%), Norges Bank (1.26%), Prudential Financial Inc. (1.04%) and Robeco Institutional Asset Management B.V. (0.99%). Company insiders that own USANA Health Sciences stock include Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Paul A Jones, Robert A Sinnott and Walter Noot. View Institutional Ownership Trends for USANA Health Sciences.

Which major investors are selling USANA Health Sciences stock?

USNA stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Fort L.P., Millennium Management LLC, Two Sigma Investments LP, Prudential Financial Inc., Bank of New York Mellon Corp, Acadian Asset Management LLC and Mackay Shields LLC. Company insiders that have sold USANA Health Sciences company stock in the last year include Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Robert A Sinnott and Walter Noot. View Insider Buying and Selling for USANA Health Sciences.

Which major investors are buying USANA Health Sciences stock?

USNA stock was bought by a variety of institutional investors in the last quarter, including Norges Bank, MERIAN GLOBAL INVESTORS UK Ltd, Nordea Investment Management AB, First Trust Advisors LP, APG Asset Management N.V., Burney Co., Bank of America Corp DE and BlackRock Inc.. Company insiders that have bought USANA Health Sciences stock in the last two years include Global Ltd Gull and Myron W Wentz. View Insider Buying and Selling for USANA Health Sciences.

How do I buy shares of USANA Health Sciences?

Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is USANA Health Sciences' stock price today?

One share of USNA stock can currently be purchased for approximately $91.41.

How big of a company is USANA Health Sciences?

USANA Health Sciences has a market capitalization of $2.13 billion and generates $1.19 billion in revenue each year. The company earns $126.22 million in net income (profit) each year or $5.16 on an earnings per share basis. USANA Health Sciences employs 1,911 workers across the globe.

What is USANA Health Sciences' official website?

The official website for USANA Health Sciences is http://www.usana.com.

How can I contact USANA Health Sciences?

USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at [email protected]


MarketBeat Community Rating for USANA Health Sciences (NYSE USNA)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  254 (Vote Outperform)
Underperform Votes:  351 (Vote Underperform)
Total Votes:  605
MarketBeat's community ratings are surveys of what our community members think about USANA Health Sciences and other stocks. Vote "Outperform" if you believe USNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USNA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/19/2019 by MarketBeat.com Staff

Featured Article: What are economic reports?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel